WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...

WASHINGTON – Following the successful launch of the 2019 National Red Ribbon Campaign earlier this month with First Lady Melania Trump at the annual Red Ribbon Rally , DEA is encouraging communities nationwide to Go Red for Red Ribbon – an effort to continue the momentum and promote awareness of...

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Susan A. Gibson, and U.S. Attorney for the District of New Jersey, Craig Carpenito, announced a Newark man today admitted possessing heroin that was seized from him at Newark Penn Station. Jeremy Lorenzo, 30, of...

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson, U.S. Attorney for the District of New Jersey Craig Carpenito, and Special Agent in Charge of the Bureau of Alcohol, Tobacco, and Firearms Newark Field Division Charlie J. Patterson, announced seventeen people...

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...

NEWARK, N.J. – The Justice Department today announced a coordinated health care fraud enforcement action across seven federal districts in the Northeastern United States, involving more than $800 million in losses and the distribution of over 3.25 million pills of opioids in “pill mill” clinics and doctors’ offices. The takedown...

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson, and U.S. Attorney for the District of New Jersey, Craig Carpenito, announced an Atlantic City, New Jersey, woman was indicted today on charges including drug distribution that resulted in a death. Rajeri...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...